Suppr超能文献

ABO血型不相容肾移植对活体供肾移植的影响。

Impact of ABO incompatible kidney transplantation on living donor transplantation.

作者信息

Yu Ji Hyun, Chung Byung Ha, Yang Chul Woo

机构信息

Transplantation research center, Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

PLoS One. 2017 Mar 21;12(3):e0173878. doi: 10.1371/journal.pone.0173878. eCollection 2017.

Abstract

BACKGROUND

ABO incompatible kidney transplantation (ABOi-KT) is an important approach for overcoming donor shortages. We evaluated the effect of ABOi-KT on living donor KT.

METHODS

Two nationwide transplantation databases were used. We evaluated the impact of ABOi-KT on overall living donor transplant activity and spousal donation as subgroup analysis. In addition, we compared the clinical outcome between ABOi-KT and ABO compatible KT (ABOc-KT) from spousal donor, and performed a Cox proportional hazards regression analysis to define the risk factors affecting the allograft outcomes.

RESULT

The introduction of ABOi-KT increased overall living donor KT by 12.2% and its portion was increased from 0.3% to 21.7% during study period. The ABOi-KT in living unrelated KT was two times higher than that of living related donor KT (17.8 vs.9.8%). Spousal donor was a major portion of living unrelated KT (77.6%) and ABOi-KT increased spousal donation from 10% to 31.5% in living donor KT. In addition, increasing rate ABOi-KT from spousal donor was 10 times higher than that of living related donor. The clinical outcome (incidence of acute rejection, allograft function, and allograft and patient survival rates) of ABOi-KT from spousal donor was comparable to that of ABOc-KT. Neither ABO incompatibility nor spousal donor was associated with acute rejection or allograft failure on multivariate analysis.

CONCLUSIONS

ABOi-KT increased overall living donor KT, and ABOi-KT from spousal donor is rapidly increasing with favorable clinical outcomes.

摘要

背景

ABO血型不相容肾移植(ABOi-KT)是克服供体短缺的重要方法。我们评估了ABOi-KT对活体供肾移植的影响。

方法

使用了两个全国性移植数据库。我们评估了ABOi-KT对整体活体供体移植活动的影响,并将配偶捐赠作为亚组分析。此外,我们比较了配偶供体的ABOi-KT和ABO血型相容肾移植(ABOc-KT)之间的临床结局,并进行了Cox比例风险回归分析以确定影响移植肾结局的危险因素。

结果

在研究期间,ABOi-KT的引入使整体活体供肾移植增加了12.2%,其占比从0.3%增至21.7%。非亲属活体供肾移植中的ABOi-KT比亲属活体供肾移植高出两倍(17.8%对9.8%)。配偶供体是非亲属活体供肾移植的主要部分(77.6%),且ABOi-KT使活体供肾移植中的配偶捐赠从10%增至31.5%。此外,配偶供体的ABOi-KT增长率比亲属活体供体高10倍。配偶供体的ABOi-KT的临床结局(急性排斥反应发生率、移植肾功能、移植肾及患者生存率)与ABOc-KT相当。多因素分析显示,ABO血型不相容和配偶供体均与急性排斥反应或移植肾失败无关。

结论

ABOi-KT增加了整体活体供肾移植,且配偶供体的ABOi-KT正在迅速增加,临床结局良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e16/5360260/fbb3d30f1b91/pone.0173878.g001.jpg

相似文献

1
Impact of ABO incompatible kidney transplantation on living donor transplantation.
PLoS One. 2017 Mar 21;12(3):e0173878. doi: 10.1371/journal.pone.0173878. eCollection 2017.
3
Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
Transplant Proc. 2020 Jul-Aug;52(6):1700-1704. doi: 10.1016/j.transproceed.2020.01.152. Epub 2020 May 21.
4
Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report.
Transplant Proc. 2021 Apr;53(3):848-855. doi: 10.1016/j.transproceed.2020.09.001. Epub 2020 Oct 9.
6
Comparison of clinical outcomes between ABO-compatible and ABO-incompatible spousal donor kidney transplantation.
Kidney Res Clin Pract. 2016 Mar;35(1):50-4. doi: 10.1016/j.krcp.2015.11.001. Epub 2016 Jan 13.
7
Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.
Am J Kidney Dis. 2020 Nov;76(5):616-623. doi: 10.1053/j.ajkd.2020.03.029. Epub 2020 Jul 12.
8
Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study.
Transplantation. 2022 Sep 1;106(9):1875-1883. doi: 10.1097/TP.0000000000004109. Epub 2022 Apr 1.
9
Borderline rejection in ABO-incompatible kidney transplantation.
Clin Transplant. 2016 Aug;30(8):872-9. doi: 10.1111/ctr.12759. Epub 2016 Jul 28.
10
Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.
Transpl Immunol. 2021 Dec;69:101476. doi: 10.1016/j.trim.2021.101476. Epub 2021 Oct 1.

引用本文的文献

2
Sex disparity in dialysis and kidney transplantation over 20 years in Korea.
Kidney Res Clin Pract. 2023 Jul;42(4):512-518. doi: 10.23876/j.krcp.22.138. Epub 2023 Mar 22.
5
Impact of high body mass index on allograft outcomes in kidney transplant recipients with presensitization to human leukocyte antigen.
Kidney Res Clin Pract. 2021 May;40(2):304-316. doi: 10.23876/j.krcp.20.216. Epub 2021 Apr 30.
6
Outcomes of kidney transplantation over a 16-year period in Korea: An analysis of the National Health Information Database.
PLoS One. 2021 Feb 19;16(2):e0247449. doi: 10.1371/journal.pone.0247449. eCollection 2021.
7
The risk factors for treatment-related mortality within first three months after kidney transplantation.
PLoS One. 2020 Dec 10;15(12):e0243586. doi: 10.1371/journal.pone.0243586. eCollection 2020.
8
Long-Term Outcome of Live Kidney Donation in South Korea.
Ann Transplant. 2020 Aug 14;25:e923065. doi: 10.12659/AOT.923065.
9
The influence of HK2 blood group antigen on human B cell activation for ABOi-KT conditions.
BMC Immunol. 2017 Dec 16;18(1):49. doi: 10.1186/s12865-017-0233-9.

本文引用的文献

1
How to reduce lethal infectious complications in ABO-incompatible kidney transplantation.
Transplant Proc. 2015 Apr;47(3):653-9. doi: 10.1016/j.transproceed.2014.11.049.
3
Initial report of the Korean Organ Transplant Registry: the first report of national kidney transplantation data.
Transplant Proc. 2014;46(2):425-30. doi: 10.1016/j.transproceed.2013.11.083.
4
Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation.
Transpl Int. 2014 Feb;27(2):187-96. doi: 10.1111/tri.12234. Epub 2013 Dec 28.
6
ABO incompatible living donor kidney transplantation in Korea: highly uniform protocols and good medium-term outcome.
Clin Transplant. 2013 Nov-Dec;27(6):875-81. doi: 10.1111/ctr.12249. Epub 2013 Oct 7.
8
Determination of rituximab dose according to immunologic risk in ABO-incompatible kidney transplantation.
Ren Fail. 2012;34(8):974-9. doi: 10.3109/0886022X.2012.700892. Epub 2012 Jul 20.
9
Outcomes of ABO-incompatible kidney transplantation in the United States.
Transplantation. 2012 Mar 27;93(6):603-9. doi: 10.1097/TP.0b013e318245b2af.
10
Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience.
Nephrol Dial Transplant. 2011 Dec;26(12):4124-31. doi: 10.1093/ndt/gfr215. Epub 2011 May 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验